Concepedia

Randomized Phase 3 Trial of Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer

Miguel Martín, Álvaro Rodríguez-Lescure, A. Ruiz, Emilio Alba, Lourdes Calvo, Manuel Ruíz‐Borrego, B. Munarriz, César A. Rodríguez, Carmen Crespo, Enrique de Álava,

JNCI Journal of the National Cancer Institute · 2008 · 238 citations · 19 references

DOIFull text

Open access

Abstract

Among patients with operable breast cancer, FEC-P treatment statistically significantly reduced the risk of relapse compared with FEC as adjuvant therapy.

References

19

Nonparametric Estimation from Incomplete Observations

Edward L. Kaplan, Paul Meier · Journal of the American Statistical Association · 1958 · 38.7K citations

, , +21

Histological Grading and Prognosis in Breast Cancer

H. J. G. Bloom, W Richardson · British Journal of Cancer · 1957 · 2.9K citations · Full text

, , +6

Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

D. Craig Allred, Jennet Harvey, Melora D. Berardo et al. · PubMed · 1998 · 2.2K citations

Polychemotherapy for early breast cancer: an overview of the randomised trials

The Lancet · 1998 · 2K citations

, , +7

Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer

I. Craig Henderson, Donald A. Berry, George D. Demetri et al. · Journal of Clinical Oncology · 2003 · 1.3K citations